Name: UMIN ID:
Unique ID issued by UMIN | UMIN000010520 |
---|---|
Receipt number | R000012303 |
Scientific Title | A phase II study of axitinib for biliary tract cancer refractory to gemcitabine-based chemotherapy |
Date of disclosure of the study information | 2013/04/18 |
Last modified on | 2013/06/29 02:42:27 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/04/17 13:16:47 | ||
2 | Update | 2013/06/29 02:42:27 | Key inclusion criteria Key exclusion criteria |